A signaling pathway linking autophagy to cancer-associated p53 dysregulation has been suggested in the literature [44]: inhibition of p53 degradation, leading to its accumulation, is able to prevent the activation of autophagy; on the contrary, in diverse conditions of p53 pharmacological inhibition or genetic depletion/deletion, autophagy can be induced. The gene discussed is TP53; the disease is cancer.